FDA approved subcutaneous pembrolizumab and berahyaluronidase alfa-pmph for solid tumors in patients 12 years and older. Recommended dosages are 395 mg/4800 units every 3 weeks or 790 mg/9600 units ...

The Altaviva device offers a minimally invasive treatment for urge urinary incontinence, with patients returning home with therapy activated. It features a 15-year battery lifespan, MRI compatibility, ...

Dornier MedTech America launched the Hoover FANS and Axis II Slim ureteroscope for kidney stone treatment in the US, both FDA-cleared. The devices are designed to integrate with Dornier’s Thulio laser ...

Rhonda Stamey, APRN, is a key member of the Advanced Therapy Center Medical Team at First Urology, where she plays an active role in advancing the treatment of prostate cancer. She provides expert ...

Apolo emphasized the value of having robust monotherapy data before advancing into combination strategies. Apolo emphasized the value of having robust monotherapy data before advancing into ...

AB001 is a novel PSMA-targeted radioligand therapy designed to treat metastatic prostate cancer with potentially higher tumor dose rates and lower normal tissue toxicity. The phase 1 trial will enroll ...

A. Lenore Ackerman, MD, PhD, discusses the renewed emphasis on symptom resolution over microbial eradication in the new AUA guideline for recurrent uUTI in women. The American Urological Association, ...

"Liquid biopsy analysis provides a noninvasive and facile tool for early detection, diagnosis, and recurrence surveillance of urological cancer," writes Jim Lu, MD, PhD.

Urology Times is the leading resource for urologists & allied health professionals offering clinical analysis, policy perspectives, & practical advice.

Ashish M. Kamat, MD, MBBS, provides expert insights into the current state of bladder cancer care, emphasizing the critical role of patient-centric approaches and exploring the evolving treatment ...

Experts discuss the ways in which AI could transform patient care and improve physician workflows, particularly for benign prostatic hyperplasia. Urology is a technology-driven field, making it an ...

The Decipher Prostate Genomic Classifier predicts docetaxel benefit in metastatic prostate cancer, especially in patients with high Decipher scores. High Decipher scores correlate with improved ...